The question isn’t just whether dementia runs in your family. It’s whether you have high cholesterol, carry extra weight, or battle hypertension on top of those worrying genes. A new study from UC San Francisco suggests that combining genetic vulnerability with cardiovascular disease markers creates a far more accurate picture of who will actually develop dementia. And crucially, it points to factors you can change.
In work published in Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association, researchers followed roughly 3,400 older adults, average age 75, for six years to build what they call a genomic-informed dementia risk report. They asked a deceptively simple question: if you add up several known risk indicators, how well does that total predict who will develop dementia?
The answer is striking. In this memory and aging clinic cohort, 81 percent of participants had at least one high-risk indicator. Each additional indicator was linked to a 34 percent increase in the hazard of dementia onset. People with four risk indicators had roughly five times the risk of those with none. Dementia risk, the findings suggest, is less a fixed sentence and more a ledger you can still help rebalance.
Four Risk Factors, Five Times the Danger
None of the participants had dementia at the study’s start, though about one in four showed mild cognitive impairment, often a precursor. By the end, one in seven had died, and one in four survivors with normal cognition or mild impairment had progressed to dementia.
The team identified four critical risk indicators actually present in the cohort: having a parent or sibling with dementia (affecting 56 percent of participants), carrying at least one APOE4 gene copy (36 percent), having elevated cardiovascular risk based on factors like obesity and hypertension (34 percent), and scoring high on a polygenic risk assessment reflecting many smaller genetic effects (11 percent). They also looked for rare autosomal dominant mutations linked to early-onset Alzheimer’s, but no participants carried them.
The pattern that emerged is almost painfully linear. Compared with people who had no risk indicators, having one was associated with a 27 percent increase in dementia hazard. Two indicators meant an 83 percent increase. Three approximately doubled the risk. Four multiplied it fivefold.
“With Alzheimer’s disease, you may have several vascular diseases involved, like hypertension and diabetes. If you make lifestyle changes and improve control of illnesses like these, you could reduce the amount of overall damage to the brain, potentially delaying or even preventing symptoms.”
That’s Shea Andrews, the study’s corresponding author, speaking to the hopeful core of this research. While you can’t edit your genes, you can manage blood pressure, lose weight, control cholesterol, exercise regularly, address hearing loss, and stay socially connected. These modifiable factors account for roughly half of dementia risk.
From Research Tool to Primary Care Conversation
The timing matters. New blood tests and specialized brain imaging can now identify Alzheimer’s in its earliest stages, when recently approved treatments might slow progression. But many people first become seriously worried about their own risk when a parent or partner receives a dementia diagnosis. That moment usually arrives in midlife, before blood-based biomarkers and imaging clearly signal Alzheimer’s pathology.
A genomic-informed risk report could meet patients and primary care clinicians exactly at that earlier point. Picture this scenario: An adult child watches a parent receive a dementia diagnosis. Concerned about their own future, they visit their family doctor. Together, they review genetic risk factors and cardiovascular metrics, translating them into an honest but actionable conversation about concrete steps to lower modifiable risks.
The researchers did not attempt to build a maximally accurate prediction model or fine-tune the weights of each factor. Instead, they wanted to test whether a straightforward, clinic-friendly tally of genomic and clinical indicators could meaningfully stratify risk. The work is grounded in an explicitly probabilistic view of Alzheimer’s disease, where monogenic mutations, APOE4, and polygenic scores represent different intensities of genetic vulnerability, and cardiovascular and lifestyle factors shape resilience or fragility on top of that.
“I think focusing on what patients can control gives them agency and ownership. This allows them to take proactive steps, rather than wait for symptoms to emerge.”
That’s senior author Kristine Yaffe, capturing what makes this approach powerful. In the vision laid out by the authors, genomic-informed risk assessments would not replace biomarkers or specialist evaluation. Instead, they would come first, helping identify who should be prioritized for more intensive monitoring, blood-based biomarker testing, and where appropriate, disease-modifying treatments. The same reports could highlight concrete targets such as blood pressure, cholesterol, weight, and physical activity as levers that patients can actually pull.
The approach mirrors successful strategies already used for heart disease prevention. When patients learn they face elevated cardiovascular risk, many make meaningful lifestyle changes and see real improvements. The hope is that similar risk communication for dementia could motivate proactive brain health strategies, especially during midlife when interventions may prove most effective.
The cardiovascular connection makes sense: the same factors that damage blood vessels in the heart also damage the delicate vasculature supplying the brain. High blood pressure, diabetes, obesity, and elevated cholesterol all contribute to vascular injury that compounds genetic vulnerability.
There’s still work to do before this approach becomes standard practice. The research cohort consisted primarily of patients already attending memory clinics, who tend to be older, more educated, and predominantly non-Hispanic white. The findings need validation in more diverse, population-based studies. Even state-of-the-art polygenic scores perform unevenly across genetic ancestries, which can amplify existing health inequities if deployed carelessly. And the team treated each piece of the risk report as equally weighted for simplicity, even though in reality these factors contribute different amounts of risk.
But the fundamental insight remains: dementia risk isn’t destiny. If risk feels inevitable, the numbers here tell a slightly different story. Genetics and cardiovascular health add up in ways that can be measured, communicated, and potentially changed. By combining genetic knowledge with attention to modifiable factors, we may finally have a practical framework for prevention, one that empowers people to take action rather than passively await an uncertain future.
Alzheimer’s & Dementia: 10.1002/alz.70826
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.
Very helpful study, thank you.